Cargando…

N6-methyladenosine associated prognostic model in hepatocellular carcinoma

BACKGROUND: N6-methyladenosine (m6A), the most internal mRNA modification, is involved in various cancers. However, the function of m6A in hepatocellular carcinoma (HCC) is still not well explored. Here, we aimed to develop a prognostic model consist of m6A associated genes in HCC. METHODS: The mRNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Hanchun, Bai, Yi, Lu, Xin, Xu, Yiyao, Zhao, Haitao, Sang, Xinting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290648/ https://www.ncbi.nlm.nih.gov/pubmed/32566570 http://dx.doi.org/10.21037/atm-20-2894

Ejemplares similares

Safety, feasibility, and efficacy of associating liver partition and portal vein ligation for staged hepatectomy in treating hepatocellular carcinoma: a systematic review
por: Zhang, Junwei, et al.
Publicado: (2020)

Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma
por: Bian, Jin, et al.
Publicado: (2021)

The diagnostic and prognostic role of RhoA in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2019)

Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2021)

Preoperative neutrophil–lymphocyte and platelet–lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma
por: Huang, Hanchun, et al.
Publicado: (2019)

Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma
por: Qi, Li-Wen, et al.
Publicado: (2021)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

Application of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma related to hepatitis B virus: comparison with traditional one-stage right hepatectomy
por: Zhang, Junwei, et al.
Publicado: (2020)

Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model
por: Zhang, Yue, et al.
Publicado: (2021)

N6-Methyladenosine RNA Methylation Regulators Have Clinical Prognostic Values in Hepatocellular Carcinoma
por: Liu, Wei, et al.
Publicado: (2020)

Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma
por: Deng, Min, et al.
Publicado: (2021)

Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model: Erratum
por: Zhang, Yue, et al.
Publicado: (2022)

Mechanisms of RNA N(6)-Methyladenosine in Hepatocellular Carcinoma: From the Perspectives of Etiology
por: Lu, Jiahua, et al.
Publicado: (2020)

Role of N6-Methyladenosine (m(6)A) Methylation Regulators in Hepatocellular Carcinoma
por: Qu, Nanfang, et al.
Publicado: (2021)

Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)

N(6)-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis
por: Zheng, Hao, et al.
Publicado: (2023)

N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma
por: Cai, Jihao, et al.
Publicado: (2021)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2022)

DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: a meta-analysis
por: Xiong, Jianping, et al.
Publicado: (2017)

Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma
por: Xiong, Jianping, et al.
Publicado: (2017)

Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systematic review and meta-analysis
por: Xiong, Jianping, et al.
Publicado: (2018)

N(6)-Methyladenosine and Viral Infection
por: Dang, Wei, et al.
Publicado: (2019)

N(6)-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling
por: Wei, Huamei, et al.
Publicado: (2023)

Comprehensive analysis of N(6)‐methyladenosine‐related long non‐coding RNAs for prognosis prediction in liver hepatocellular carcinoma
por: Zhu, Hong‐Xu, et al.
Publicado: (2021)

Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets
por: Zhou, Yu, et al.
Publicado: (2019)

N(6)-methyladenosine (m(6)A) RNA methylation regulators are associated with clinical prognosis in hepatocellular carcinoma
por: Li, Gao, et al.
Publicado: (2020)

Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients
por: Zheng, Xinyu, et al.
Publicado: (2023)

Prognostic implications of N(6)-methyladenosine RNA regulators in breast cancer
por: Tai, Jiaojiao, et al.
Publicado: (2022)

Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma
por: Zhang, Lemeng, et al.
Publicado: (2021)

Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma
por: Bian, Saiyan, et al.
Publicado: (2020)

The role of RNA N(6)-methyladenosine methyltransferase in cancers
por: Huang, Jiali, et al.
Publicado: (2021)

Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinoma
por: Sun, Huishan, et al.
Publicado: (2023)

The emerging roles of N(6)-methyladenosine in osteoarthritis
por: Liu, Hui, et al.
Publicado: (2022)

RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance
por: Zhao, Hua, et al.
Publicado: (2021)

Evolution of transcript modification by N(6)-methyladenosine in primates
por: Ma, Lijia, et al.
Publicado: (2017)

Association of N6-methyladenosine with viruses and related diseases
por: Wu, Fang, et al.
Publicado: (2019)

Differentially expressed liver exosome-related genes as candidate prognostic biomarkers for hepatocellular carcinoma
por: Zuo, Bangyou, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5e54paepj323kgf6namtg4kddu